[Selected parameters of antioxidant capacity in renal allograft recipients].
Various oxidant species, oxygen free radicals (OFR) implicated in patients with chronic renal diseases treated with dialysis and after cadaveric renal transplantation. Oxidative stress occurs when free radical generation exceeds antioxidant defence. We therefore examined markers of lipid peroxidation and antioxidant potential in blood (serum, plasma, RBC) of very carefully (clinically and biochemically) selected 102 subjects (56 female and 46 male, mean age 37.5 +/- 7 years). Included were 51 renal allograft recipients (RARs); 15 patients with glomerulopathies (GL); 36 healthy age- and sex-matched volunteers as a control group (C). All RARs were divided into two subgroups: RARs-A (n = 28) were treated with triple drug therapy including cyclosporin A (CsA) and RARs-Z (n = 23) were on double drug regimen: prednisone, azathioprine. Patients with coronary artery disease (CAD), diabetes, serum creatinine concentration > 2.0 mg/dl, acute rejection and infections were excluded. We used several automated assays to estimate: malondialdehyde (MDA); total radical-trapping antioxidant potential (TRAP), glutathione peroxidase (GPx), glutathione (GSH), superoxide dismutase (SOD), catalase (CAT), vit. E and lipid profiles. Patients of RARs-A were found to have significantly elevated triglycerides; cholesterol-LDL; MDA; TRAP and decreased activity of RBC glutathione peroxidase as compared with those of RARs-Z and group C.


CONCLUSIONS
our data show that oxidative stress (with prooxidant effect of CsA partly at least), with reduced in antioxidant potential of defences system is associated with kidney transplantation.
Juskowa
J
J
Klinika Immunologii, Transplantologii i Chorób Wewnetrznych Instytutu Transplantologii AM w Warszawie.
Paczek
L
L
Laskowska-Klita
T
T
Rancewicz
Z
Z
Gajewska
J
J
Jedynak-Ołdakowska
U
U
D000328:Adult; D000975:Antioxidants / Q000378:metabolism*; D005260:Female; D005609:Free Radicals / Q000378:metabolism; D006801:Humans; D006949:Hyperlipidemias / Q000175:diagnosis / Q000453:epidemiology; D007676:Kidney Failure, Chronic / Q000378:metabolism* / Q000503:physiopathology / Q000601:surgery*; D016030:Kidney Transplantation; D015227:Lipid Peroxidation / Q000502:physiology; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism*; D018384:Oxidative Stress / Q000502:physiology; D014184:Transplantation, Homologous
D000975:Antioxidants; D005609:Free Radicals; D008315:Malondialdehyde
Wybrane wskaźniki systemu przeciwutleniajacego u biorców allogennej nerki.